Wei Ruan
阮伟
Wei Ruan is the founder and CEO of Naxions (诺信创联), a Chinese pharma-tech SaaS company that uses data and technology to reshape the pharmaceutical supply chain. Per a 2015 meeting note from Frees Fund, he was seen as someone with deep understanding of pharmaceutical-industry demand and a rare combination of both IT and sales expertise . The company has raised multiple rounds, including a $15 million round in 2019 and an A+ strategic round in 2018 that included IQVIA as a backer . Elsewhere's corpus does not cover his personal background or more recent developments beyond the 2019-2020 window.
AI-generated — may contain errors, please verify.
Coverage
Network Effects — Possibly One of the Best SaaS Business Models | Frees Fund: Learning from Investing
Tough businesses that address long-standing contradictions always represent outsized opportunities.
"Nuoxin Chuanglian" Raises $15 Million in Funding | FreeS Fund Deal News
A new-generation leader in the life sciences marketing space.
IQVIA Makes a Move in China, "Nuoxin Chuanglian" Raises Tens of Millions of RMB in A+ Strategic Round | FreeS Fund Deal News
Version 2.0 pharmaceutical marketing digitalization solution.
